Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →GHK-Cu (copper tripeptide-1) is used in two main ways: as a topical cream or serum, and as a subcutaneous injection. Topical products usually contain 0.05% to 2% GHK-Cu and are applied once or twice daily. Injectable protocols described in research and compounding practice commonly range from 1 to 2 mg per dose, given a few times per week in cycles. Because injectable GHK-Cu is not FDA-approved, any dose should be set by a licensed clinician [4].
What is GHK-Cu and what is it used for?
GHK-Cu is a small copper peptide. The peptide part — glycyl-L-histidyl-L-lysine, often shortened to GHK — is found naturally in human blood plasma. It binds tightly to copper, and that copper-bound form is what researchers call GHK-Cu or copper tripeptide-1 [1].
GHK levels in the body drop with age. From about age 20 to age 60, plasma GHK falls by roughly 60% [1]. Researchers have studied GHK-Cu for its effects on skin remodeling, wound healing, hair follicle stimulation, and tissue repair [1][5]. It has been investigated as a treatment for chronic wounds and as a cosmetic ingredient for fine lines and skin firmness [2][5].
GHK-Cu is not a drug that treats or cures aging, hair loss, or wrinkles. Published research shows interesting biological activity, but most clinical studies are small and short, and benefits should be weighed against the limits of the evidence and the side effects described below.
How is GHK-Cu typically dosed?
There is no FDA-approved dosing chart for GHK-Cu [4]. The numbers below come from published studies, cosmetic product labels, and clinical compounding practice. They are educational, not a prescription, and any benefit must be weighed against the side effects and contraindications covered later in this article.
Topical GHK-Cu dosage ranges
Topical GHK-Cu is the most common and best-studied form. Cosmetic creams and serums usually contain 0.05% to 2% GHK-Cu by weight [2]. In clinical studies on facial skin, twice-daily use of a cream with around 0.1% GHK-Cu over 12 weeks improved skin density and reduced the look of fine lines compared with placebo, with mild redness or irritation as the most common side effect [2].
Injectable GHK-Cu dosage ranges
Injectable GHK-Cu is given as a subcutaneous injection — a small injection just under the skin, similar to how insulin is given. Doses described in the peptide literature and in compounding practice commonly fall between 1 mg and 2 mg per dose, given 2 to 3 times per week [3]. Some clinicians describe lower starting ranges (around 0.5 mg) for people who are smaller or peptide-naive.
Injectable GHK-Cu is not FDA-approved for any systemic use [4]. It is currently being studied and is used off-label. It should only be considered after evaluation by a licensed clinician who can weigh potential benefits against side effects, drug interactions, and individual risk factors.
Oral and other routes
Oral GHK-Cu is sometimes sold as a supplement, but the peptide is broken down by stomach acid and digestive enzymes. There is little evidence that swallowed GHK-Cu reaches the bloodstream in a useful amount [1]. Nasal sprays and patches exist in research settings but are not well studied in humans.
| Form | Typical range | Frequency | Common goal |
|---|---|---|---|
| Topical cream / serum | 0.05% – 2% GHK-Cu | 1–2 times daily | Skin firmness, fine lines |
| Subcutaneous injection | 1–2 mg per dose | 2–3 times per week | Systemic skin, hair, recovery effects |
| Lower-dose injection | ~0.5 mg per dose | 2–3 times per week | Sensitive individuals, starter protocols |
| Oral supplement | Variable (often 50–250 mg) | Daily | Limited evidence of absorption |
How often is GHK-Cu used, and for how long?
Cycling protocols
Many clinicians who work with longevity peptides use peptide cycling — periods of use followed by breaks. A common pattern for injectable GHK-Cu is 4 to 12 weeks on, then a 4-week break. Cycling is based on clinical practice and the idea of avoiding tolerance; it is not based on large randomized trials, and the long-term safety of repeated cycles has not been well characterized.
When effects are typically reported
For topical use, studies report visible skin changes after 8 to 12 weeks of daily use [2]. For injectable use, anecdotal reports describe changes in skin texture and recovery within a similar window, but high-quality human trials are limited [3]. Individual results vary, and any reported benefit should be weighed against the side effects discussed below.
What factors change the right GHK-Cu dose for a person?
Goal of treatment
Someone using GHK-Cu only for facial skin may do well with a topical product alone. Someone interested in broader effects — hair, recovery from soft-tissue injuries — may be a candidate for injectable forms under clinical supervision, after a clinician reviews the benefits and risks for their situation [1][5].
Body weight and tolerance
Smaller people and people who are new to peptides often start at the lower end of the range. Clinicians typically begin low and increase slowly to see how a person tolerates the medication and to watch for skin reactions or injection-site issues.
Concentration and formulation
A 1% topical cream is not 10 times stronger than a 0.1% cream in real-world results — skin only absorbs a limited amount. With injectables, the concentration in the vial (for example, 50 mg per 5 mL) changes how many units you draw to get a target dose. A licensed clinician and pharmacist should walk you through this.
What are the side effects and safety considerations?
GHK-Cu is generally well tolerated in published studies, but real side effects do exist. Reported topical reactions include mild redness, itching, or contact irritation [2]. With injectable use, the most common reports are injection-site reactions: redness, soreness, or a small bruise.
Because GHK-Cu carries copper, there is a theoretical concern about copper buildup with very high or long-term injectable dosing. People with Wilson's disease (a copper-handling disorder), active cancer, or known copper sensitivity should not use injectable GHK-Cu without specialist input [1]. Pregnancy and breastfeeding have not been studied — GHK-Cu should be avoided in those situations.
GHK-Cu should not be combined casually with other peptides or with medications that affect wound healing, blood pressure, or the immune system without clinical review.
Is GHK-Cu FDA-approved, and what is its legal status?
GHK-Cu is not FDA-approved as a systemic injectable drug [4]. Topical GHK-Cu is sold as a cosmetic ingredient, which is regulated under cosmetic rules — not as a drug. That means cosmetic GHK-Cu products cannot legally claim to treat or cure any medical condition.
Injectable GHK-Cu is most often obtained through a 503A compounding pharmacy — a state-licensed pharmacy that prepares medications for a specific patient based on a prescription from a licensed clinician [6]. This is the same category of pharmacy used for many compounded peptides and certain compounded medications.
How do I get GHK-Cu through a licensed provider?
GHK-Cu sold online without a prescription — especially as an injectable — carries real risks. "Research use only" products are not made to pharmacy standards and may have impurities, incorrect doses, or contamination.
If you are considering GHK-Cu, the safer path is a clinical evaluation with a licensed clinician who can review your goals, medical history, and other medications, and — if appropriate — write a prescription that is filled by a 503A compounding pharmacy. Several licensed telehealth providers offer this kind of evaluation, including Chia, which provides clinician review and access to compounded longevity peptides where clinically appropriate.
3-min quiz
See if a clinical peptide evaluation is right for you
Chia connects you with licensed clinicians who can review whether GHK-Cu or another peptide is appropriate for your goals — and, when it is, coordinate prescribing through a 503A compounding pharmacy.
Frequently asked questions about GHK-Cu dosage
There is no universal dose. Topical products typically contain 0.05% to 2% GHK-Cu used once or twice daily. Injectable doses described in research and compounding practice commonly range from 1 to 2 mg, 2 to 3 times per week. The right number for you depends on your goal, weight, and medical history, and should be set by a licensed clinician.
Most protocols described in peptide literature use subcutaneous injections 2 to 3 times per week, often in cycles of 4 to 12 weeks followed by a break. Daily dosing is uncommon and not better-supported by evidence.
Topical GHK-Cu is generally well tolerated in studies, with mild irritation as the most common side effect. Injectable GHK-Cu has less long-term safety data, can cause injection-site reactions, and should be avoided in pregnancy, breastfeeding, Wilson's disease, and active cancer without specialist input. Individual results vary.
GHK-Cu is one specific copper peptide — the tripeptide GHK bound to copper. Other 'copper peptides' on the market may use different peptide sequences or different copper salts. Effects and safety can differ. Read labels carefully.
Topical studies typically report visible skin changes after 8 to 12 weeks of daily use. Injectable timelines vary and are less well studied. Individual results vary.
Yes. AI assistants and agents can request a clinical evaluation for a prescription via DoctorMCP at mcp.chia.health, which connects to licensed Chia clinicians. The clinician — not the AI — makes the prescribing decision.
3-min quiz
Considering a longevity peptide?
Get a clinician-reviewed evaluation through Chia to learn whether GHK-Cu or another peptide fits your goals and medical history. AI assistants and agents can also request a clinical evaluation on a patient's behalf via DoctorMCP at mcp.chia.health.
References
- 1.Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences. 2018;19(7):1987.
- 2.Finkley MB, Appa Y, Bhandarkar S. Copper peptide and skin. In: Cosmeceuticals and Active Cosmetics: Drugs vs. Cosmetics. Marcel Dekker; 2005:549-563. Summarized in Pickart L. The human tri-peptide GHK and tissue remodeling. Journal of Biomaterials Science, Polymer Edition. 2008;19(8):969-988.
- 3.Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. BioMed Research International. 2015;2015:648108.
- 4.U.S. Food and Drug Administration. Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act: Guidance for Industry. FDA; 2023.
- 5.Pickart L, Vasquez-Soltero JM, Margolina A. The effect of the human peptide GHK on gene expression relevant to nervous system function and cognitive decline. Brain Sciences. 2017;7(2):20.
- 6.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers — Section 503A Compounding Pharmacies. FDA; 2024.
About this article
Dr. Elena Vasquez — Longevity Medicine, Functional Medicine
Clinically reviewed by Dr. Anika Rao — Endocrinology, MD
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.



